Beranda › Karsinoma Sel Renal Metastatik Sel Jernih
Uji klinis Karsinoma Sel Renal Metastatik Sel Jernih yang merekrut di AS
17 studi untuk Karsinoma Sel Renal Metastatik Sel Jernih merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Baldwin Park, CA7 studi
- Dallas, TX5 studi
- Nashville, TN5 studi
- New York City, NY5 studi
- Rochester, MN4 studi
- Waukegan, IL4 studi
- St. Louis, MO4 studi
- Phoenix, AZ3 studi
- San Diego, CA3 studi
- Orlando, FL3 studi
- Omaha, NE3 studi
- Cleveland, OH3 studi
- Jacksonville, FL3 studi
- Irvine, CA3 studi
- Boston, MA3 studi
- Portland, OR3 studi
- Houston, TX3 studi
- Queens, NY3 studi
- Philadelphia, PA3 studi
- Ann Arbor, MI3 studi
- San Francisco, CA3 studi
Berdasarkan negara bagian
- Arizona4 studi
- Arkansas3 studi
- California9 studi
- Florida4 studi
- Illinois5 studi
- Massachusetts4 studi
- Michigan4 studi
- Minnesota5 studi
- Missouri4 studi
- Nebraska3 studi
- New Jersey3 studi
- New York6 studi
- Ohio3 studi
- Oregon3 studi
- Pennsylvania4 studi
- South Carolina4 studi
- Tennessee6 studi
- Texas6 studi
- Virginia3 studi
- Washington3 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07011719Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma
Menerima pesertaFase 1
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07748988Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07227415Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05361720A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT07195682Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT07300241Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06866262Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC)
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT07179770Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT05263050Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT07043608Imaging of Solid Tumors Using 18F-TRX
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT06942104Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Jul 2026 · NCT07128680Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Jun 2026 · NCT07383441VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Jun 2026 · NCT07510334Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Mar 2026 · NCT06349642Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2025 · NCT04510597CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Mei 2024 · NCT06399419Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.